Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(17%)
Results Posted
14%(1 trials)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (9.1%)
N/A10 (90.9%)

Trials by Status

completed758%
unknown325%
recruiting217%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12